MAGLE
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Magle Chemoswed is founded on strategic acquisitions aimed at driving growth and diversifying risk. The Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.
Lue lisääLiikevaihto milj.
EBIT-% (oik.)
EPS (oik.)
Osinko %
Osavuosikatsaus Q2'26
Osavuosikatsaus Q3'26
Vuosikatsaus '26
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.